BIOMAT Database Logo BIOMAT Database Logo

Thrombin promotes angiogenesis by a mechanism independent of fibrin formation. 1993

N E Tsopanoglou, and E Pipili-Synetos, and M E Maragoudakis
Department of Pharmacology, University of Patras Medical School, Greece.

The role of thrombin in angiogenesis was investigated in the chick chorioallantoic membrane (CAM) system. alpha-Thrombin promoted angiogenesis in a dose-dependent fashion and at 8.4 pmol/disk reached a maximum of 78% above the control. At a higher dose of alpha-thrombin (25 pmol/disk) the angiogenic effect declines and this can be explained by desensitization of the thrombin receptor. The promotion of angiogenesis by alpha-thrombin is specific as evidenced by the reversal of this effect by hirudin, which binds both the catalytic and the anion-binding exosite of thrombin or by heparin, which binds thrombin and accelerates its inactivation by antithrombin III. gamma-Thrombin, which is catalytically active but lacks the anion-binding exosite required for clotting activity, promotes angiogenesis in the CAM in the same fashion and to the same extent as alpha-thrombin, at doses up to 130 pmol/disk. Phenylalanyl-propyl-arginine chloromethyl ketone (P-PACK)-thrombin, the catalytically inactive analogue of alpha-thrombin that retains the anion-binding exosite, had no significant effect on angiogenesis in the CAM. When combined with alpha-thrombin, P-PACK-thrombin abolished the angiogenesis-promoting effect of alpha-thrombin. These results suggest that alpha-thrombin can promote angiogenesis in the CAM through interaction with its catalytic site without the requirement for fibrin formation.

UI MeSH Term Description Entries
D009389 Neovascularization, Pathologic A pathologic process consisting of the proliferation of blood vessels in abnormal tissues or in abnormal positions. Angiogenesis, Pathologic,Angiogenesis, Pathological,Neovascularization, Pathological,Pathologic Angiogenesis,Pathologic Neovascularization,Pathological Angiogenesis,Pathological Neovascularization
D002642 Chick Embryo The developmental entity of a fertilized chicken egg (ZYGOTE). The developmental process begins about 24 h before the egg is laid at the BLASTODISC, a small whitish spot on the surface of the EGG YOLK. After 21 days of incubation, the embryo is fully developed before hatching. Embryo, Chick,Chick Embryos,Embryos, Chick
D002823 Chorion The outermost extra-embryonic membrane surrounding the developing embryo. In REPTILES and BIRDS, it adheres to the shell and allows exchange of gases between the egg and its environment. In MAMMALS, the chorion evolves into the fetal contribution of the PLACENTA. Chorions
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D005337 Fibrin A protein derived from FIBRINOGEN in the presence of THROMBIN, which forms part of the blood clot. Antithrombin I
D000481 Allantoin A urea hydantoin that is found in URINE and PLANTS and is used in dermatological preparations. Herpecin-L,Sebical,Woun'dres,Herpecin L,HerpecinL
D000590 Amino Acid Chloromethyl Ketones Inhibitors of SERINE ENDOPEPTIDASES and sulfhydryl group-containing enzymes. They act as alkylating agents and are known to interfere in the translation process. Peptide Chloromethyl Ketones,Chloromethyl Ketones, Peptide,Ketones, Peptide Chloromethyl
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000991 Antithrombins Endogenous factors and drugs that directly inhibit the action of THROMBIN, usually by blocking its enzymatic activity. They are distinguished from INDIRECT THROMBIN INHIBITORS, such as HEPARIN, which act by enhancing the inhibitory effects of antithrombins. Antithrombin,Direct Antithrombin,Direct Antithrombins,Direct Thrombin Inhibitor,Direct Thrombin Inhibitors,Antithrombin, Direct,Antithrombins, Direct,Inhibitor, Direct Thrombin,Thrombin Inhibitor, Direct,Thrombin Inhibitors, Direct
D013917 Thrombin An enzyme formed from PROTHROMBIN that converts FIBRINOGEN to FIBRIN. Thrombase,Thrombin JMI,Thrombin-JMI,Thrombinar,Thrombostat,alpha-Thrombin,beta,gamma-Thrombin,beta-Thrombin,gamma-Thrombin,JMI, Thrombin

Related Publications

N E Tsopanoglou, and E Pipili-Synetos, and M E Maragoudakis
Mechanism of thrombin binding by fibrin.
January 1981, Annals of the New York Academy of Sciences,
N E Tsopanoglou, and E Pipili-Synetos, and M E Maragoudakis
By increasing the affinity of heparin for fibrin, Zn(2+) promotes the formation of a ternary heparin-thrombin-fibrin complex that protects thrombin from inhibition by antithrombin.
October 2012, Biochemistry,
N E Tsopanoglou, and E Pipili-Synetos, and M E Maragoudakis
Formation of anticoagulants by digesting fibrin with thrombin.
July 1968, Thrombosis et diathesis haemorrhagica,
N E Tsopanoglou, and E Pipili-Synetos, and M E Maragoudakis
Mechanism of thrombin-induced angiogenesis.
April 2002, Biochemical Society transactions,
N E Tsopanoglou, and E Pipili-Synetos, and M E Maragoudakis
[Study of the mechanism of coagulation in the guinea pig. II. Thrombin formation and fibrin formation].
June 1965, Revue canadienne de biologie,
N E Tsopanoglou, and E Pipili-Synetos, and M E Maragoudakis
Heparin promotes the binding of thrombin to fibrin polymer. Quantitative characterization of a thrombin-fibrin polymer-heparin ternary complex.
January 1990, The Journal of biological chemistry,
N E Tsopanoglou, and E Pipili-Synetos, and M E Maragoudakis
Fibrin formation and proteolysis during ancrod treatment. Evidence for des-A-profibrin formation and thrombin independent factor XIII activity.
January 2001, Annals of the New York Academy of Sciences,
N E Tsopanoglou, and E Pipili-Synetos, and M E Maragoudakis
Thrombin generation, fibrin clot formation and hemostasis.
February 2008, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis,
N E Tsopanoglou, and E Pipili-Synetos, and M E Maragoudakis
Antithrombin I. Inhibition of thrombin generation in plasma by fibrin formation.
January 2003, Thrombosis and haemostasis,
N E Tsopanoglou, and E Pipili-Synetos, and M E Maragoudakis
Inhibition of thrombin generation in plasma by fibrin formation (Antithrombin I).
August 2002, Thrombosis and haemostasis,
Copied contents to your clipboard!